Dudediligence.

Biogen Inc

BIIBNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

147.8M

on 2026-07-27, from 145.6M on 2024-04-23 10-Q ↗

50M100M150MApr2024JulDecApr2025JulDecApr2026Jul

Newest

No limit

S-3ASR of 2025-05-01. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

2 of its filings are not read yet.

Warrants

The 10-Q filed 2026-07-29 is not read yet.

Cash

Four quarters of operating cash flow to 2026-06-30 are not all on file.

Raised: 3 of its filings are not read yet.

Also on file: $2.00B term loan, 2026-05-12 8-K ↗